182 related articles for article (PubMed ID: 19077160)
21. Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group.
Schmid H; von Schenck U; Hartmann R; Borgmann A; Henze G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():28-30. PubMed ID: 8932794
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
[TBL] [Abstract][Full Text] [Related]
23. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
24. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
26. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
[TBL] [Abstract][Full Text] [Related]
27. Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
Wu S; Gessner R; Taube T; von Stackelberg A; Henze G; Seeger K
J Clin Oncol; 2005 May; 23(13):3038-42. PubMed ID: 15860861
[TBL] [Abstract][Full Text] [Related]
28. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Tolar J; Bostrom BC; La MK; Sather HN
Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
[TBL] [Abstract][Full Text] [Related]
29. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
Borgmann A; von Stackelberg A; Hartmann R; Ebell W; Klingebiel T; Peters C; Henze G;
Blood; 2003 May; 101(10):3835-9. PubMed ID: 12732501
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
Klimza MJ; Sońta-Jakimczyk DJ
Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
[TBL] [Abstract][Full Text] [Related]
31. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T
J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992
[TBL] [Abstract][Full Text] [Related]
32. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.
Chan LL; Abdel-Latif ME; Ariffin WA; Ariffin H; Lin HP
Br J Haematol; 2004 Sep; 126(6):799-805. PubMed ID: 15352983
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of acute lymphoblastic leukemia subclasses in 28 Thai children--a preliminary study.
Angchaisuksiri P; Atichartakarn V; Apibal S; Salakit C; Mahasandana C; Supradish P; Hathirat P
J Med Assoc Thai; 1992 Jan; 75 Suppl 1():209-16. PubMed ID: 1402467
[TBL] [Abstract][Full Text] [Related]
34. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia.
Viana MB; Fernandes RA; de Carvalho RI; Murao M
Int J Cancer Suppl; 1998; 11():56-61. PubMed ID: 9876480
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors analysis in a therapeutic trail of acute lymphoblastic leukaemia (ALL).
Kabir A; Begum M
Bangladesh Med Res Counc Bull; 2002 Apr; 28(1):19-25. PubMed ID: 12587757
[TBL] [Abstract][Full Text] [Related]
36. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts.
Peters C; Schrauder A; Schrappe M; von Stackelberg A; Stary J; Yaniv I; Gadner H; Klingebiel T;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S9-11. PubMed ID: 15812540
[TBL] [Abstract][Full Text] [Related]
38. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan.
Mori T; Takimoto T; Katano N; Kikuchi A; Tabuchi K; Kobayashi R; Ayukawa H; Kumagai MA; Horibe K; Tsurusawa M
Br J Haematol; 2006 Mar; 132(5):594-7. PubMed ID: 16445832
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig WD; Henze G; Gadner H; Odenwald E; Riehm H
Leukemia; 2000 Dec; 14(12):2205-22. PubMed ID: 11187912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
